leukocyte integrin Mac-1 modulator program (Sujana Biotech)

N/A

Report date: 2025/03/20 15:07:01
NME

Base Information

Drug Nameleukocyte integrin Mac-1 modulator program (Sujana Biotech)
Drug Alias Nameleukocyte integrin Mac-1 modulator program (Case Western Reserve University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-M modulators
TargetsIntegrin alpha-M
Therapy Area/IndicationsInflammationMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesSujana Biotech LLC
Inactive CompaniesN/A
Active IndicationsInflammationMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A